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Abstract
Background/Aims: Recently, next-generation sequencing-based technologies have enabled DNA methylation profiling at
high resolution and low cost. Methyl-Seq and Reduced Representation Bisulfite Sequencing (RRBS) are two such
technologies that interrogate methylation levels at CpG sites throughout the entire human genome. With rapid reduction of
sequencing costs, these technologies will enable epigenotyping of large cohorts for phenotypic association studies. Existing
quantification methods for sequencing-based methylation profiling are simplistic and do not deal with the noise due to the
random sampling nature of sequencing and various experimental artifacts. Therefore, there is a need to investigate the
statistical issues related to the quantification of methylation levels for these emerging technologies, with the goal of
developing an accurate quantification method.
Methods: In this paper, we propose two methods for Methyl-Seq quantification. The first method, the Maximum Likelihood
estimate, is both conceptually intuitive and computationally simple. However, this estimate is biased at extreme
methylation levels and does not provide variance estimation. The second method, based on Bayesian hierarchical model,
allows variance estimation of methylation levels, and provides a flexible framework to adjust technical bias in the
sequencing process.
Results: We compare the previously proposed binary method, the Maximum Likelihood (ML) method, and the Bayesian
method. In both simulation and real data analysis of Methyl-Seq data, the Bayesian method offers the most accurate
quantification. The ML method is slightly less accurate than the Bayesian method. But both our proposed methods
outperform the original binary method in Methyl-Seq. In addition, we applied these quantification methods to simulation
data and show that, with sequencing depth above 40–300 (which varies with different tissue samples) per cleavage site,
Methyl-Seq offers a comparable quantification consistency as microarrays.
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Introduction
DNA methylation is an epigenetic regulatory mechanism im-
plicated with various human diseases [1,2]. cytosine nucleotides
in DNA molecules, primarily in the CpG context, may be methy-
lated, and the changes in DNA methylation status can modulate
expression levels of genes [3,4,5,6,7] and therefore phenotype
[8,9,10,11].
In the past, measurement of DNA methylation was only feasible
and affordable for a small number of individuals at a limited number
of sites. Recently, genome-scale technologies have been developed
for profiling DNA methylation status of individuals, including
sequencing-based technologies that can survey DNA methylation
levels genome-wide with base-pair resolution [12,13,14].
With the advancement of sequencing technology, the cost
of large-scale sequencing has dropped considerably. Therefore,
genome-wide epigenetic association studies may soon become
feasible in large cohorts. At present, however, genome-wide
sequencing of methylation is most economical when the DNA
samples are first enriched with target regions by genome partition
techniques. There are a number of such technologies available
to investigators. See recent reviews [12,13] for the experimental
aspects of these technologies. In this work, we focus on Methyl-Seq
[15] and RRBS [16], two leading high resolution next-generation
sequencing-based technologies.
In Methyl-Seq [15], genomic DNAs from the same biological
sample are digested by enzymes MspI and HpaII, respectively.
MspI cleaves all 59-CCGG-39 sites; while HpaII cleaves only
unmethylated 59-CCGG-39 sites. The digested fragments are then
subject to size-selection, which acts to enrich the CpG-containing
regions in the fragment library. Afterwards, the selected frag-
ments are sequenced on the next-generation sequencing platform.
Sequence tags in MspI digestions delineate ‘‘assayable’’ sites, while
sequence tags in HpaII digestion identify unmethylated sites
specifically. Thus the methylation level at each assayable site can
be inferred by the presence or absence of HpaII tags. In RRBS,
genomic DNAs are also first enriched for CpG contents by MspI
digestion. However, the methylation status of sites is probed by
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methylated cytosine nucleotides into uracils (and read out as ‘T’s),
and the methylation status of a site can be inferred by comparing
the sequence tag to the reference genomic sequence. Methyl-seq
and RRBS technologies are different in the way methylation
signals are measured. The Methyl-Seq performs methylation-
specific digestion and thus only reads out signals at 59-CCGG-39
sites, while RRBS performs bisulfite sequencing which reads
out signals at all cytosine nucleotide positions in the selected
fragments.
Both Methyl-Seq and RRBS data involve methylation-sensitive
tag counts and are likely to benefit from statistical methods for the
quantification of methylation levels, rather than direct read
counting. For Methyl-Seq, Brunner et al. [15] used the binary
call of methylation level. However, since most experiments involve
heterogeneous mixtures of tissues or cells with different methyl-
ation levels, ideally the methylation proportionmshould be treated
as a continuous variable between 0 and 1 that reflects the
percentage of methylated molecules in the mixture of cells from
which the DNA was sampled. Moreover, Brunner et al.[15] ’s
estimation is only based on HpaII tag counts whereas MspI tag
counts are merely used to delineate ‘‘assayable’’ regions and HpaII
tag counts are used to make a binary call. It would be reasonable
that combining the tag count information of MspI and HpaII
naturally contribute to proportion estimate in the methylation
quantification. For RRBS, the natural quantification of methyl-
ation level at CpG dinucleotides would be the number of tags with
C divided by the total number of tags. For both Methyl-Seq and
RRBS, due to the random sampling nature of shotgun sequencing,
the coverage at different sites varies and thus the variance of the
estimates for the methylation level can be large and heteroge-
neous. It would be desirable in this sequence-based technology to
estimate the variance of methylation level, which is potentially
useful for further epigenetic association studies. Since the Methyl-
Seq technology was developed very recently, there have been very
few methods developed for statistical quantification for Methyl-
Seq and RRBS data. Recently, the MetMap program developed
by Singer et al. [17] infers site-specific methylation probabilities by
a statistical graphic model. This program primarily focuses on the
setting where paired-end HpaII fragment libraries without
corresponding MspI libraries are sequenced, resembling the
methylation sensitive cut counting approach [18]. In addition,
the MetMap program infers strongly unmethylated islands with a
hidden markov model like structure.
In this work, we study the statistical issues relating to the
quantification of methylation levels by next-generation sequencing
technologies: Methyl-Seq and RRBS. Since the quantification of
RRBS is relatively straightforward, we mainly focus on Methyl-
Seq. Unlike MetMap, we assume that both the MspI-digested and
the HpaII-digested libraries are available, and we do not assume
paired-end information. We present two new methods to quantify
methylation levels for Methyl-Seq data: one maximum likeli-
hood estimate and the other in a Bayesian hierarchical model
framework. Our Bayesian method, based on a Poisson thinning
process [19], can accommodate varying sequencing depth among
different genomic regions. We compare the performances of our
models with both simulated and real data.
In addition to algorithm development, we investigate a few
experimental design questions regarding quantification of meth-
ylation levels in next-generation sequencing. We compare the site-
level versus the region-level quantification. Moreover, we estimate
the necessary sequencing depth, at which Methyl-Seq can offer
a comparable quantification consistency as microarray. Finally,
although the quantification for RRBS is more straightforward
than Methyl-Seq, we reveal an important difference of the va-
riances of these two technologies.
Methods
2.1 Background on Methylation estimation in Methyl-Seq
(Brunner et al.)
Using next-generation sequencing, Methyl-Seq assays over
250,000 methylation-sensitive restriction enzyme cleavage sites
grouped into over 90,000 regions. In their original paper, Brunner
et al. [15] demonstrated the Methyl-Seq technology by analyzing
the methylation pattern for 13 human tissue types. In their ex-
periments, one control sample of HCT116 tissue type was digested
by MspI and 13 different tissue samples were digested by the
methylation-sensitive enzyme HpaII. Because of some technical
replicates, one MspI library and 15 HpaII libraries were generated
(see Supplementary Table 2 of Brunner et al. [15] for details).
These digested fragments undergo fragment size selection, and
most fragments are of length 35–75 bps. Because the enzyme
cleavage sites 59-CCGG-39 contain a CpG sites and CpG sites are
known to be clustered, the size selection process will enrich the
presence of CpG sites in the library. After size-selection, these
libraries were subjected to next-generation sequencing, resulting
approximately 3 million tags (sequencing reads) per HpaII library
and 10 million tags for the MspI library.
The following bioinformatics processing was conducted to
obtain tag counts at each digestion site. First, all reads were
mapped to the reference human genome sequence. Not all CCGG
sites in the human genome are covered by sequencing reads due to
the fragment size selection and various sequencing biases. In
practice, only those digestion sites that are covered by four or more
MspI reads in either forward or backward direction were deemed
as ‘‘assayable’’ sites. For assayable sites, the tag counts in both
forward and backward directions for each library were recorded.
We downloaded the tag count data from the Myers lab website at
HudsonAlpha (http://myers.hudsonalpha.org/content/protocols.
html). Since methylation levels at nearby sites are typically
highly correlated, Brunner et al. [15] grouped digestion sites in
neighboring 35–75 bps into a ‘‘region’’ and methylation levels
were called at the region level. Brunner et al.[15] ’s methylation
estimate was binary: a region in a library is either methylated or
unmethylated. Specifically, in a region containing n sites, they used
the HpaII tag counts at the i-th site, which is defined as yi. After
grouping sites into previously determined assayable regions, each
region’s methylation level was called based on the average HpaII
tag count  y y. Regions with   y y .1 were called unmethylated, the
methylation level m~0; otherwise were called methylated m~1.
To validate the Methyl-Seq technology, Brunner et al.[15]
compared the Methyl-Seq tag counts with the results of the
Infinium Human Methylation 27 BeadChips (Illumina), a stan-
dard technology for quantification of DNA methylation levels. For
each of the CpG sites represented on this array, the beta value,
calculated based on the intensities of the relevant probes, estimates
the percent of DNA molecules being methylated. The comparison
between Methyl-Seq and the microarray experiment was based on
four tissue sample libraries: HCT116, H9 hESC, H9 endoderm and
adult liver with overall 160 matching regions.
As a quantitative measure of the consistency between Methyl-
seq and Infinium microarray, Brunner et al.[15] use the Receiver
Operating Characteristic (ROC) curve. Basically, they dichoto-
mize microarray beta values as the gold-standard (.0.6 as
methylated and ,0.6 as un-methylated), and consider average
HpaII tag counts as the predictor. As a result, average HpaII tag
Statistics of Methylation Sequencing
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0.944 (Figure 1C in Brunner et al. [15]).
2.2 Methyl-Seq Data Processing and Observations
In the present work, we use the Brunner et al. data set and
discuss statistical issues relevant to Methyl-Seq. Due to this some-
what complicated experimental procedure, it may be beneficial
to first review a few decisions made during the data processing,
before presenting our observations on the issue of statistical quan-
tification.
In a Methyl-Seq data set, there are two tag reads at each site,
one on the forward strand and one on the reverse strand. While
Brunner et al. used the larger of the forward and reverse tag counts,
it can be tempting to use the tag counts for both forward and
reverse reads. Ideally, If paired-end read libraries were used such
as in [17], i.e., a pair of reads from both ends of a fragment, one on
the forward strand and one on the reverse strand, are sequenced, it
is possible to keep track of all fragments. However, when paired-
end reads are not available it is not a simple problem to infer all
fragment information. Moreover, under ideal conditions, the
forward and the reverse tag counts at site i should be equal, as they
both represent the digestion at that site. In reality, these forward
and reverse counts may not be equal: it could simply be a
reflection of the fact that site i-1 is further away from site i than site
i+1, and it is sequenced less easily. In fact, when the next site is too
far away, site i would only have reads from one strand. This gets
even more complex with HpaII, as the distance to the next site is
determined by the distance to the next unmethylated site. In the
extreme, there will be no site for many kilobases, and the fragment
will only be sequenced in one direction, so the forward reads will
be present and the reverse reads absent (or nearly so). Therefore,
for HpaII digestion, simply counting both forward and reverse
reads will inflate the tag count at sites that are between two other
nearby unmethylated sites. While a full treatment of the
directionality of reads may be possible with a much more
complicated model with explicit representation of fragments, we
follow Brunner et al. [15] in this work and use the larger of the
forward and reverse read counts.
Also, like Brunner et al. [15], we use the Infinium microarray
experiment data as gold-standard reference. In addition to the
microarray data used in Brunner et al. [15], we also use two
n e wt i s s u es a m p l el i b r a r i e s :BG02 hESC and BG02 EB-derived
cells. We implemented a new background normalization
procedure to the microarray data to improve the quantifica-
tion. This involved subtracting the median of the negative
control probes on each array from the red and green color
channels, and recalculated methylation levels as b/(a+b),
where b is the background-subtracted intensity from the
methylated probe and a is the background-subtracted intensity
from the unmethylated probe. We identified 151 regions in 6
tissue libraries matched between Methyl-Seq and microarray
experiments. After eliminating 9 missing values within the
newly generated microarray data, the comparison is based on
897 methylation beta values. The AUC of Methyl-Seq tag
counts in our data set is 0.9556, slightly higher than that in the
Brunner et al, [15] analysis.
To conduct a statistical analysis of the Methyl-Seq data, we
define the following notations. For an assayable CCGG site i,w e
use xi denoting its MspI tag count and yi denoting its HpaII tag
count. Following Brunner et al.[15], we use the larger of the
forward and reverse tag counts at each site in a region. Also, we
assume that all CCGG sites in a region have the same methylation
level and we will quantify the methylation level for each region. In
the present work we consider one HpaII library at a time, although
there might be correlation of methylation levels among different
libraries at the same site.
With this setup, we have the following observations on this data
set. First, Brunner et al.[15] ’s estimation only includes the HpaII
tag counts information, whereas MspI tag counts are only used to
delineate ‘‘assayable’’ regions. We understand that it is not the
primary interest of Brunner et al. to give a continuous estimate of
the methylation percent. However, with the MspI tag count
information, it is possible to make proportional estimates between
Figure 1. Correlation of 16 Tissue Sample Libraries. Spearman correlations among tag counts in MspI (X) library and 15 HpaII libraries (Y1–Y15).
doi:10.1371/journal.pone.0021034.g001
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of methylated molecules from which DNA was sampled. The
naı ¨ve proportional estimate for the HapII library j would be
1{
PK
i~1 yij
.PK
i~1 xi, where K is the total number of sites in a
region.
Second, due to the random sampling nature of sequencing, for a
given region in MspI and HpaII library sample j, the HpaII tag
count
PK
i~1 yij of all K sites is not always smaller than the MspI
tag count
PK
i~1 xi. Therefore, the simple proportional estimate
1{
PK
i~1 yij
.PK
i~1 xi may be negative and thus the estimate has
to be revised.
Third, certain genome-wide correlation structures exist among
the tag counts in these libraries (Figure 1). Primarily, the control
Library (X: HCT 116 - MspI) digested with MspI has spear-
man correlation 0.11,0.21 with libraries digested by HpaII
Yj,j~1,2,:::15. This correlation results from sequence-specific
biases in the library construction process and the sequencing
process, together with methylation effect. These effects are difficult
to disentangle, but we can simply model them by introducing
certain correlation between X andYj. Besides, all pairs of libraries
digested by HpaII show a high correlation (spearman correlation
r(Yk,Yl)§0:60, where k, l stands for any pair of HpaII libraries).
This reflects the basal pattern of methylation that is unchanged
among different cell types. Moreover, HpaII libraries from the
same tissue samples (such as Y3–Y9 from H9) have generally an
even higher correlation (spearman r(Yk,Yl)§0:83), suggesting
tissue-specific methylation profiles. Finally, technical replicates
typically have the highest correlation. This is the case for Y1 and
Y2 (spearman r(Y1,Y2)~0:91), and for Y11 and Y12 (spearman
r(Y11,Y12)~0:90).
To allow for a statistical analysis of the Methyl-Seq data, we
explore some assumptions pertaining to the distribution of tag
counts. Assuming genome-wide uniform sequencing depth, the
MspI and HpaII tag counts along the genome can be appro-
ximated by Poisson distribution, where the tag counts’ Poisson
mean l is the sequencing depth of MspI library [20]. However,
since the sequencing depth is not constant throughout the whole
genome, instead of using a constant depth parameter l in Poisson
distribution for the whole genome, our analysis uses dynamic
sequencing depth parameter li for each cleavage site i’s MspI
library tag count: xi*Poisson(li) where xi stands for the MspI
library tag count for each cleavage site i. Moreover, Ji et al.[21]
suggest that the ChIP-Seq tag counts can be better fitted with a
negative-binomial distribution. A negative-binomial distribution
can be modeled as a continuous Gamma-Poisson mixture
structure [22], that is, we can fit xi*Negbin(ri,pi) with the
hierarchical model xi*Poisson(li) and the Poisson rate li
conditional on pi and ri: li ri,pi j *Gamma(ri,(1{pi)=pi), where
pi is a proportion parameter, and ri is the over-dispersion
parameter. In this way, Poisson assumption is a special case
nested in the Negative-binomial assumption. Our analyses
considered both assumptions and used the Gamma-Poisson
mixture framework. We also define a constant Beta-value, the
methylation level m for each HpaII library in a specific region.
Following Brunner et al.[15] ’s analysis on restriction enzymes,
each HpaII tag is an independent Bernoulli with parameter1{m.
To estimate the methylation level m, we propose two methods:
Truncated Proportional Estimate (TPE), and Bayesian Hierarchi-
cal method. Both methods are detailed below.
2.3 Truncated Proportional Estimate
We assume the following model for generating the tag counts in
Methyl-Seq experiment. For a region with K assayable CCGG sites,
the HpaII tag count at the i-th site in j-th technical replicates, yij,i s
generated by first generating xi’ total sequencing tags, and then sub-
sampled by a fraction (1-m), where m is the methylation level of the
region.Inanotherwords,yijjx0
i*Binomial(x0
i,1{m),wh er ex0
i isthe
corresponding unobserved MspI tag count sample, generated from
the samedistribution asxi: Poisson(li) orNegbin(ri,pi).W i t he i t h e r
Poisson or more general negative-binomial assumption, we can
deriveyij’s marginal distribution respectively: yij*Poissonfli(1{m)g
or yij*Negbinfri,pi=(1{mzmpi)g. Regardless of the assumption
of Poisson or negative binomial distribution of tag counts, we can
use xi and yij’s log-likelihood to derive the same maximum
likelihood estimate of m: max(1{
PK
i~1 yij
.PK
i~1 xi,0). We called
this estimate the Truncated Proportional Estimate (TPE): the term
PK
i~1 yij
.PK
i~1 xi estimate the proportion of unmethylated DNA
and is consistent with the intuitive proportion between HpaII and
MspI tag counts; when this term exceed one, methylation estimate is
truncated to 0. TPE includes both MspI and HpaII sequence tag
counts information as well as their random sampling nature into the
estimation.
The TPE method is attractive since it is simple in calculation
and does not depend on specific assumptions. However, this
method cannot provide methylation levels’ variance estimate. On
the one hand, since sequencing coverage is not consistent among
the whole genome, the variance of the methylation level can be
large and heterogeneous. Therefore, estimation of the variance is
often desired in association studies. On the other hand, based on
Brunner et al.[15] ’s reported sequencing data, 77% of all 90,612
regions in the whole genome are composed of only two digestion
sites, and 95% of regions in the whole genome contain no more
than 5 digestion sites. Therefore, the sample size for methylation
estimate is small, and it may be not appropriate to use the
observed information matrix [23] of Maximum Likelihood
Estimation to approximate the estimates’ variance. Moreover,
because of the truncation toward 0 when
PK
i~1 yijw
PK
i~1 xi, the
proportional estimate is biased downward. To alleviate the lack of
estimates’ variance and the extreme bias at high HpaII count cases
(low methylation), we consider a Bayesian Hierarchical model
approach.
2.4 Bayesian Hierarchical Model
Bayesian hierarchical models have been successfully applied in
modeling ChIP-Seq data [24] and RNA-Seq data [25], because
they offer flexibility in modeling complex processes of generating
sequencing tag counts. Moreover, Bayesian hierarchical models
framework allow estimation of the posterior distribution of
parameters, and therefore their variances.
With the Poisson assumption of tag counts, the MspI tag
count xijli*Poisson(li), and each HpaII tag count is an
independent Bernoulli with parameter1{m, then the HpaII tag
countyi can be considered as the result of a Poisson thinning
process [19], and is distributed with yij(li,m)*Poissonfli(1{m)g:
If we assume the negative-binomial model of tag counts
and consider the Gamma-Poisson mixture, we can specify
the distribution of the sequencing depth li conditional on pi
and ri: lijri,pi*Gammafri,(1{pi)=pig where piis a proportion
with 0vpiv1,a n dri with riw0 is over-dispersion parameter,
which reflects the extra variance of xi beyond the Poisson
assumption. When ri approaches infinity, the negative-binomial
assumption is equal to the Poisson assumption. For the final level of
the hierarchy, without any prior information of methylation level m,
piand ri, we use non-informative priors for these parameters. In
summary, our hierarchical model is:
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lijri,pi*Gamma fri,(1{pi)=pig, i~1,2,   ,K, where K is the
number of sites in a region,ri*uniform(0,200), where 200 is a
large number which stands for approximation to infinity;
pi*uniform(0,1),m*uniform(0,1):
Then the joint posterior density of li,ri,piandm can be expressed
as:
p(li,ri,pi,mjx,y)!Pifp(xijli):p(yijli,m):p(li ri,pi j ):p(ri):p(pi)g:p(m)
In order to compute the posterior estimates and variance of
parametersli,ri,pi andm, we use the Markov Chain Monte Carlo
(MCMC) to generate posterior samples from the posterior
distribution of the parameters. In the following analysis, we fit
the Bayesian model using Winbugs software [26]. We ran three
different chains from independent initial values, and specify 500
iterations as burn-in. After convergence, there are 500 iterations to
generate posterior distribution for all parameters. Since there are
overall 3K+1 parameters to be estimated in the model and most of
regions are composed of small number of cleavage sites K, the
MCMC algorithm converges quickly. With the generated
posterior samples, we can compute posterior mean as methylation
estimate and its variance.
2.5 Flexible Structure to Adjust Sequencing Depth Bias
Within Brunner et al.[15] ’s data, sequencing is performed
generally deeper on MspI libraries than on HpaII libraries, and
the bias is different between HpaII libraries and regions. In
Brunner et al. ’s original analysis, since methylation binary call only
depends on the HpaII tag count, it is not a crucial problem.
However, the sequencing depth bias affects MspI and HpaII
libraries’ tag counts differently, and it should be adjusted for the
estimation of methylation levelmin our models. Lacking the bias
information for each region, we use genome-wide CGG tags
aligned to MspI sites (see Supplementary Table 2, last column, of
Brunner et al.[15]) as the reference, and define the ratio of MspI
library to each HpaII library to specify its sequencing depth bias
dj. Recognizing that this ratio combines the methylation effect
with sequencing depth bias, the adjustment is only approximate.
Both the Bayesian Hierarchical model and the TPE mo-
del provide flexible structures to adjust this known biases
dj. For instance, Bayesian method’s hierarchical distributions
change to: xijli*Poisson(li), yijj(li,m,dj)*Poissonflidj(1{m)g,
and other terms remain unchanged. Meanwhile, TPE ofmcan
also incorporate the sequencing depth bias, and changes to:
max(1{dj
P
i yij
 P
i xi,0).
Results
3.1 Evaluation Quantification by Simulation Study
We use simulation studies to evaluate the proposed Bayesian
estimate and the Truncated Proportional Estimate (TPE). We first
generate a methylation levelmfrom the empirical density of
Microarray beta value from Brunner et al.[15], and then generate
cleavage site number K of each region based on Methyl-Seq real
data’s empirical distribution of sites. In this way, simulated data
scenario is as similar to the real data example as possible. In
the simulation, we assume that MspI tag counts are Poisson
distributed, and design the sequencing depth to be a constant
value, such as 50. Meanwhile, we consider the same sequencing
depth of MspI and HpaII libraries, and thus there is no sequen-
cing depth bias. We generate each site’s MspI tag counts
xi*poisson(50), and HpaII tag counts yij*poissonf50(1{mj)g,
where j~1,2,   ,6: Overall, we simulated 6 tissue libraries’ tag
counts, across 155 regions, with total 930 methylation levels to be
estimated. In addition, to compare the quantification by Methyl-
Seq in different sequencing depths, we generated simulation data
for 9 different sequencing depths increasing from 40 to 350.
We applied TPE and Bayesian estimation methods to simu-
lation data. In Figure 2, we plot two different methods estimates
with sequencing depth 50 vs. the true methylation levels. It is
shown in the plots that TPE as well as Bayesian estimate has
increasing variance as methylation levelmdecreases. Moreover,
TPE shows a prominent truncation at zero at low methylation
level, which is not the case for Bayesian estimate. Overall,
Bayesian Hierarchical estimate correlate with true methylation
beta value better than TPE (t-test [27] for Pearson correlation
differences 0.007, p-values ,0.001).
As another way to compare different methods’ estimates, we
follow Brunner et al. [15] and create estimates’ ROC curves. We
compare the estimates of the methylation level by the Brunner et
al. ’s HpaII tag count, TPE, and Bayesian methods with
dichotomized microarray beta values. Because of the dichotomi-
zation of microarray data, the ROC evaluation is not as sensitive
as correlation analysis. Still, ROC serves as an alternative
evaluation of quantification and a better estimation method
should have a higher area under the ROC curve (AUC). What we
found is that, consistent with the Pearson correlation result,
Bayesian Hierarchical estimate slightly outperforms the truncated
proportional estimate with a higher AUC (data not shown).
3.2 Evaluation of Quantification by Real Methyl-Seq Data
We next applied the Truncated Proportional Estimate (TPE)
and Bayesian estimate to quantify the methylation levels in
Brunner et al.[15] Methyl-Seq data set, which is introduced in
Methods section 2.2. In addition, we use the adjustment in
Methods section 2.5, with genome-wide CGG tags information to
specify the overall library-wide sequencing depth as mentioned in
Brunner et al.[15]. In Figure 3, we plot the TPE and the Bayesian
estimates against the microarray beta value. For both estimation
methods, most of data points cluster around lower-left (‘‘low-low’’)
and upper-right (‘‘high-high’’) corners. This indicates that the
Methyl-Seq estimates which coincide with microarray beta values
usually occur in high methylation (m is close to 1) or low
methylation levels (m is close to 0). However, a notable fraction of
Methyl-Seq estimates deviate from microarray beta values, visible
on the plots of Figure 3 as off-diagonal points, reflecting that either
of two estimates does not fit the microarray beta value as well as
the simulation study. Overall, the Bayesian estimates achieve a
correlation of 0.893 with the microarray beta values; while that
correlation for the TPE method is 0.889. This difference is
significant (t-test for correlation difference 4610
23, p=0.013).
While this overall high correlation levels reflect the fact that
both TPE and Bayesian methods are capable of capturing the
binary ‘‘high-low’’ classification of methylation levels, it is worth-
while to investigate the detailed quantification performance at
‘‘high-high’’ and ‘‘low-low’’ regions. In Figure 3, if we consider the
‘‘low-low’’ region with both the TPE and Bayesian estimates, as
well as the microarray beta values all less than 0.5, the correlation
of Bayesian estimate is 0.207, while the correlation of TPE is
0.158. On the other end, if we consider the ‘‘high-high’’ region
with both the TPE and Bayesian estimates, as well as the
microarray beta value greater than 0.5, the correlation of Bayesian
Statistics of Methylation Sequencing
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while TPE apparently truncated some points at zero, Bayesian
method eliminated these truncated estimates.
In fact the difference of quantification of TPE and the Bayesian
method is more pronounced than the overall correlation suggested
as shown in Figure 3. TPE’s estimates are sharply concentrated at
extreme values: zero and one. This is because that the truncation
acts in regions where HpaII tag counts exceed MspI tag counts
and thus forces the methylation estimates to 0, and in regions
devoid of HpaII tags and thus the methylation estimates are
exactly at 1. The Bayesian estimates do not show such sharp trun-
cations, and thus are more amicable for real-world applications.
It is also shown from the ROC curves comparison (Figure 4)
that TPE and Bayesian estimate have generally overlapping ROC
Figure 3. Performance of proposed estimates on Methyl-Seq real data. Comparison of the proposed estimates (TPE and Bayesian Estimate)
in real Methyl-Seq experiment and microarray methylation beta values. Bayesian estimate has significantly higher correlations than TPE
(p-value=0.012, t test).
doi:10.1371/journal.pone.0021034.g003
Figure 2. Performance of proposed estimates on simulation data at sequencing depth 50. Comparison of the proposed estimates (TPE
and Bayesian Estimate) and the true methylation proportions in simulation. Bayesian estimate have significantly higher correlation (pearson r=0.981)
than TPE (pearson r=0.973) (p-value,0.001, t test).
doi:10.1371/journal.pone.0021034.g002
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count. Moreover, the Bayesian estimate has a slightly larger AUC
than TPE.
3.3 Necessary Depth Required by Methyl-Seq to Offer a
Comparable Quantification Accuracy as Microarrays
The estimate of methylation level in Methyl-Seq, as a count-
based quantification, is more accurate with higher sequencing tag
counts. A practical question is, at what sequencing depth can
Methyl-Seq offer a better quantification than microarrays. We
found 3 tissue sample libraries with technical replication data in
microarray methylation experiments on the Infinium Methyl 27
platform: H9 hESC (2 replicates, with correlation 0.9946); BG02
EB delivered cells (3 replicates, with pairwise correlations 0.9836,
0.9808 and 0.9700); and adult liver (2 replicates with correlation
0.9718). To achieve the same level of consistency of technical
replicates with Methyl-Seq, one has to increase the sequencing
depth. We simulate with different sequencing depths ranging from
40 to 350. It is clear from Figure 5 that the consistency
(correlation) improves with increasing sequencing depth. It is also
shown in Figure 5 that Bayesian method’s correlation is always
higher than TPE. To achieve a microarray’s consistency, the
Bayesian method needs sequencing depth about 40–250 per
cleavage site while TPE would need 50–300. As a cautionary note,
we remark that the correlation between repeated simulations’
estimates is a measure of consistency, whereas the actual accuracy
should be estimated by the correlation between the estimate and
the true values, which is not yet available for our data set.
Nonetheless the high accuracy shown in Figure 2 suggests that the
consistency is a good estimate of the accuracy.
3.4 Site-level versus Region-level Quantification
A key advantage of Methyl-Seq/RRBS over ChIP-based
methylation quantification technologies such as MeDIP [28] is
that Methyl-Seq and RRBS can offer single base-pair resolution
methylation status. We compare the site-level versus the region-
level quantification using simulation. For simplicity, we only
consider two sites in a region, and assume that MspI tag counts are
fixed on sequencing depth, with a constant value l. Meanwhile, we
consider the same sequencing depth of MspI and HpaII libraries,
and generate each site’s MspI tag counts xi~l,for i~1,2,
HpaII tag counts yi*poissonfl(1{m)g. We first use the em-
pirical density of microarray beta values [15] to fit the methy-
lation level m with a marginal beta distribution, resulting with
Beta(0:222,0:715), and then generate methylation level ms for two
neighborhood sites with the same marginal distribution but
different correlation [29], increasing from 0.92 to 1. Overall, we
simulated 2000 sites for each correlation from 0.92 to 1. In
addition, to compare the quantification in different sequencing
depths, we generated simulation data with sequencing depths l 30
and 300.
As shown in Figure 6, we found that the site-level quantification
is more accurate when the sequencing depth is high or the
correlation of methylation levels between nearby sites is low. When
Figure 4. ROC curve Comparison of proposed estimates with Brunner et al. ’s estimate. ROC curves for three quantification methods:
Brunner Estimate (HpaII tag count), Truncated Proportional Estimate (TPE), and Bayesian Estimate. Following Brunner et al., microarray beta values are
treated as gold-standard and dichotomized with .0.6 for methylated and ,0.6 for un-methylated. The Brunner, TPE, and Bayesian estimates are
treated as predictors, and each point on the plot represents a cutoff values on the continuous-valued predictor.
doi:10.1371/journal.pone.0021034.g004
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between nearby sites is high, quantification by region will be more
accurate than quantification by sites as it allows borrow infor-
mation across all sites in a region. In many practical settings
including the Brunner et al. [15] experiment, the sequencing depth
is relatively low. Region-level quantification may be more appro-
priate in such cases.
3.5 Sensitivity of the estimators to different sequencing
depths of MspI and HpaII libraries
A simplifying assumption in our analysis on Methyl-Seq data is
that the sequencing depths in MspI library and HpaII library are
equal, i.e., lMspI~lHpaII. It would be helpful to know to what
extent different depths are tolerated by the noise in the system.
Here we investigate the effect of different sequencing depths in
MspI and HpaII libraries on the estimate by simulation. We use
the simulation procedure as described above in Results section 3.1
to simulate regions and sites, except that we generate 9 con-
figurations of sequencing depths lMspI and lHpaII. Specifically, we
consider three different MspI sequencing depths: low (lMspI =5),
medium (lMspI =30), and high lMspI =300). To control the level
of sequencing depth discordance between the HpaII library and
the MspI library, we generate the HpaII sequencing depth using
log-normal distribution: log(lHpaII)*N( log(lMspI), s2). For each
MspI setting we consider three levels of sequencing depth
discordance with s from 0, 0.5 to 1. For each combination of
lMspI and s we generate 100 data sets, each with 6 tissue libraries’
tag counts, across 155 regions, with total 930 methylation levels to
be estimated. We run TPE and Bayesian model and compare the
estimates to the true levels.
As shown in Figure 7, we found that the quantification accuracy
plummeted as the sequencing depth discordance increases: At
sequencing depths of 30 or above, the correlation is above 95%
when no discordance exist, while the correlation is about 90% with
modest discordance (s=0.5), and the correlation is at 80% or
lower when high discordance exists (s=1). Meanwhile, the
quantification with higher sequencing depth always helps. While
there is a huge difference between low (lMspI =5) and medium
(lMspI =30) sequencing depths, additional sequencing depths
above 30 seems only to increase correlation 2%–3%. Besides
these patterns, it is also shown that the Bayesian estimates are
consistently better than the Truncated Proportional Estimates.
In many practical settings, including Brunner et al. ’s real data,
the sequencing depths of the MspI and HpaII libraries are
correlated but are not guaranteed to be the same, ie, there exists
regional variations of sequencing depth in the experiment, even
after the global library-wide sequencing depth is adjusted. While
our model assumes no discordance between the sequence depths
among libraries, our results suggest that the Bayesian model
displays a higher level of robustness to this unknown noise than the
naı ¨ve TPE model.
As a caveat, a scatter plot (Supplementary Figure S1) suggests
that the heavy distribution of TPE estimates at extreme values
(zero and one) in real data might be due to low sequencing depths
in some regions.
3.6 Comparison of Methyl-Seq and RRBS in terms of the
variance of their quantification
The quantification of RRBS data is relatively straightforward in
the spirit of proportional estimate. For a site with a C nucleotide in
Figure 5. Quantification consistency of proposed estimates with increasing sequencing depth. Consistency of the proposed estimates
for increasing sequencing depths in Methyl-Seq. Consistency is the average correlation between the measurements from technical replicates.
Simulated technical replicates are generated from repeated sampling of the same underlying true methylation levels.
doi:10.1371/journal.pone.0021034.g005
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PLoS ONE | www.plosone.org 8 June 2011 | Volume 6 | Issue 6 | e21034Figure 6. Comparison of performances of site level and region-level Bayesian estimations at high and low sequencing depths. The
region-level estimation’s accuracy increases rapidly with higher correlation, while the site-level estimation’s accuracy remains stable. The region-level
estimation has clear advantage for higher correlation region sites or lower sequencing depth, while the site-level estimation has better result for
lower correlation region sites and higher sequencing depth.
doi:10.1371/journal.pone.0021034.g006
Figure 7. Effect of sequence depth difference between MspI and HpaII. Methyl-Seq assumes that MspI and HpaII sequencing tags share the
same sequence depth l. In many practical settings, the sequence depths are correlated but may not be the same. We consider the sequence depth
difference with log(lHpaII)*N( log(lMspI), s2), and compare the average correlation while the deviation s changes from 0, 0.5 to 1. Furthermore, we
consider the sequence depths difference effect in three settings: low sequencing depth lMspI with 5, medium sequence depth lMspI with 30, as well
as extremely high sequencing depth lMspI with 300. The sequence depth difference brings accuracy to drop rapidly. The effect of sequence depth
difference is more heavy than the sequence depth.
doi:10.1371/journal.pone.0021034.g007
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number of sequencing tags with ‘C’ at the site as x, and the
number of sequencing tags with ‘T’ at the site as y, and the
methylation level at the site would be simply x/(x+y). This site-level
estimate can be generalized to region-level estimate as Sxi/
S(xi+yi), where the xi and yi are the sequencing tag counts of site i
in the region.
Using simulation, we reveal, however, that Methyl-Seq’s TPE
and RRBS’s proportional estimates have different behavior in
terms of the variances of their estimates. For convenience of
comparison, we apply the RRBS simulation procedure similar
to Methyl-Seq in Results section 3.1, and simulate the regions,
sites, and tag counts with the same sequencing depth 50 as in
Methyl-Seq, except that we assume yi*poissonf50(1{m)g, and
xi*poisson(50m). As shown in Figure 8, RRBS’s estimates has a
relatively equal level of variance near m=0 and m=1. This is in
dramatic contrast to the Methyl-Seq’s TPE estimate shown in
Figure 2, where the variance is higher in the near m=0 range.
This reflects the nature of the data rather than the biases in
these estimates. In Methyl-Seq, the MspI tag counts serve as a
‘‘control’’ of the HpaII tag counts. At sites where methylation level
is low, the HpaII counts can be high but the MspI tag counts may
be low and thus TPE truncation happens or the MspI tag counts
may be very high and thus the proportional estimate can be quite
different from the true methylation level. Noise of MspI tag counts
in either direction can result in large deviation of TPE from the
true value. At sites where methylatioin is high, the HpaII tag
counts tend to be low, the variation of MspI tag counts would have
a smaller effect on proportional estimates. In RRBS, the ‘C’ tag
counts and the ‘T’ tag counts are symmetric and variances of the
proportional estimate at either extremely high or extremely low
methylation levels behave similarly. See Supplementary Part A in
Materials S1 for a proof sketch for these arguments.
Discussions
Methyl-Seq and other emerging sequencing-based technologies
can measure DNA methylation levels in a sample efficiently.
However, to the best of our knowledge, there is no investigation on
the statistical issues related to the quantification of methylation
levels in Methyl-Seq and other methylation sequencing data. In
this study, we introduced two different methods for estimating the
methylation levels for the Methyl-Seq technology: one intuitive
Truncated Proportional Estimate (TPE) based on Maximum
Likelihood estimation and the other in Bayesian hierarchical
framework. Comparing these quantification methods through
simulation and real Methyl-Seq data, we demonstrated that
Bayesian hierarchical model outperforms the TPE, while both
methods are significantly better than the binary quantification in
the original Methyl-Seq paper [15]. This result indicates that the
Bayesian hierarchical structure can effectively capture the
statistical signals in the complex experimental design of Methyl-
Seq. While TPE is conceptually simple and easy to implement, we
recommend using Bayesian hierarchical structure as the statistical
quantification method for Methyl-Seq.
In addition, we investigated several statistical issues relating to
methylation quantification by sequencing. We found that, to
achieve a quantification quality comparable to microarrays,
Methyl-Seq should be conducted with at least sequencing depth
40–250 per cleavage site for both MspI and HpaII libraries. Also,
Figure 8. Performance of proposed estimates on RRBS simulation data. The RRBS data simulation is similar with Methyl-Seq data simulation.
But we assume that yi*poissonf50(1{m)g,and xi*poisson(50m). The Methylation level’s variation keep consistent when m=0 and m=1, which is
different from Methyl-Seq in Figure 2, where m’s variation inflates as m decreases from 1 to 0.
doi:10.1371/journal.pone.0021034.g008
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over using TPE to achieve the same level of quantification quality.
Finally, we revealed an important difference between the variances
of Methyl-Seq and RRBS: Methyl-Seq has an inflated variance for
methylation level estimates at lowly methylated sites, while RRBS
does not have such an artifact. All quantification methods for
Methyl-Seq and RRBS have been implemented in an R-package,
msBayes, freely available at http://www.ssg.uab.edu/wiki/dis-
play/SQML/Home.
There are additional biases in the Methyl-Seq data that have
not yet been adjusted in our models. First, since methylation status
and sequencing depth are coupled in the HpaII library, the overall
library-wide sequencing depth might be underestimated by
Brunner et al. by adjusting it with genome-wide CGG tags aligned
to MspI sites [15]. While we followed Brunner et al. ’s procedure,
one possible future improvement is to iteratively re-adjust the
overall library-wide sequencing depth after the quantification of
methylation levels. Second, a major confounding factor for
methyl-sequencing data is that the read frequency for a specific
restriction site depends not only on the DNA methylation status at
this particular site, but also on the DNA methylation status of
neighboring sites. This is because, in order to obtain an HpaII
read at site i, there has to be another HpaII cleavage site not too
far from site i to present a fragment for sequencing. Third, the
regional sequencing coverage li is associated with many factors
such as GC content, a common issue faced by many other
sequencing-based technologies. It would be interesting to borrow
ideas from other sequencing-based technologies such as RNA-Seq.
For example, we can apply the Poisson log linear regression in our
Bayesian hierarchical structure to model the sequencing prefer-
ence by predicting li from local sequences [30]. Fourth, in the
context of Methyl-Seq and RRBS, an additional complicating
factor is the selection bias of enzyme-cleaved fragments with
different lengths (Supplemental Figure 4 of Brunner et al. [15]).
The lengths of these fragments are associated with the regional
density of 59-CCGG-39 sites. Our Bayesian model might be
improved by incorporating components adjusting these biases and
addressing these biases will be topics for future research. Fifth and
finally, fragment size selection is an important source of
sequencing depth bias, as shown in Supplemental Figure 4 in
Brunner et al. Also, the variance/range of fragment sizes could
influence the definition of regions in our quantification. As a
background model, a restriction enzyme which is not only non-
methylation dependent but also non-GC rich might be interesting
to study as it teases out many sequence-dependent fragment
selection biases.
In the present work, we follow the definition of regions by
Brunner et al.[15]. Region definition is important as our models
assume that methylation levels within a region remain a constant.
We recognize that this region definition is rather simplistic. It is
known that methylation levels can fluctuate even between nearby
sites. More flexible constraints on the auto-correlation of
methylation levels among neighboring sites may be explored as
additional hierarchies in the Bayesian framework in the future. For
example, one may incorporate a correlation matrix among
neighboring sites.
The Reduced Representation Bisulfite Sequencing (RRBS) is an
alternative sequencing-based technology for methylation quanti-
fication [16]. Similar to Methyl-Seq, RRBS is also a count-based
sequencing technology, using restriction enzymes to recognize 59-
CCGG-39 sites for enrichment of CpG sites. Unlike Methyl-Seq,
RRBS uses bisulfite conversion technology and obtains both the
tag counts for methylated and unmethylated DNAs from one
tissue sample. However, RRBS may have distinct sources of biases
such as the noisy alignment due to a reduced genome alphabet
and noisy base calling at the first position of the fragment. Current
quantification frameworks of both the TPE and the Bayesian
Hierarchical model can be extended to quantify the RRBS data,
with the Bayesian model is more promising in terms of handling
the biases from diverse sources.
Supporting Information
Figure S1 Performance of proposed estimates on sim-
ulation data at low sequencing depth. TPE and Bayesian
estimates of methylation levels in simulation data generated using
low sequencing depth (lMspI =5). Please see Results section 3.5 in
the main text for detailed simulation procedure. By visual
comparison with Figure 3 in the main text, this result suggests
that the extreme TPE estimates (zeros and ones) in the real data
might be due to the setting of low sequencing depth.
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